Oklahoma lawmaker files bill to prohibit those under 21 from getting gender reassignment medical treatment

An Oklahoma lawmaker has filed legislation aimed at preventing people under the age of 21 from undergoing gender reassignment medical treatment in the state.State Sen. Warren Hamilton said he filed Senate Bill 676, which would make it illegal for a person under the age of 21 to undergo gender reassignment chemical or surgical procedures, for a parent or guardian to pursue gender reassignment procedures for a person younger than 21, or for a health care professional to intentionally perform the gender reassignment procedures on anyone under 21.According to Hamilton, the bill defines gender reassignment medical treatment as any health care … Read More

Local woman receives antibody treatment for COVID-19

YRMC rep confirms it offers this treatment to qualifying patients – News 11’s Arlette Yousif reports

YUMA, Ariz. (KYMA, KECY) – A combination of two drugs, casirivimab, and imdevimab, can be used as a COVID treatment for patients who qualify.

The emergency use authorization was issued by the Food and Drug Administration back in November but has not been widely discussed.

In addition to testing positive for COVID, qualifying COVID patients are those who have one or more of the following:

  • Weigh less than 88 pounds (12 years of age and older)
  • Select high-risk health conditions
  • Mild to moderate COVID
Read More

As COVID-19 Rips Through Travis County Jails, Inmates Say They’re Not Getting Access To Medical Treatment

In late January, Neffitinni Gutierrez assured her three young sons everything was going to be OK, that she’d see them soon. She hung up the phone knowing those assurances were half-truths.

In recent weeks, things hadn’t been OK for her in the Travis County Correctional Complex, where she’s awaiting trial for three nonviolent drug offenses and an auto-theft charge.

She’d been given the wrong medicine, causing an adverse reaction that sent her to the ICU at Ascension Seton. She hadn’t been given proper medical assistance for her diabetes or her asthma or the two respiratory conditions she suffers from.

She’d

Read More

Utah lawmaker wants to prohibit doctors from offering gender reassignment treatment to minors

SALT LAKE CITY — A southern Utah lawmaker wants to prohibit doctors from offering any gender reassignment treatment to minors.

“These are young kids … these are minors that — and I do have a lot of empathy for maybe kids feeling like they’re a male in a female body or vice versa — but these puberty blockers that they take can have permanent effect on their bodies,” said bill sponsor Rep. Rex Shipp, R-Cedar City.

Under HB92, physicians and surgeons would be restricted from performing gender reassignment treatment on those under 18, including internal surgeries and facial feminization

Read More

Medical Waste Treatment Service Market 2021, Share, Growth, Trend, Industry Analysis and Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Jan 29, 2021 (Heraldkeepers) —
Summary

A New Market Study, titled “Medical Waste Treatment Service Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

This report provides in depth study of “Medical Waste Treatment Service Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Waste Treatment Service Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product

Read More

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Malignant mesothelioma is intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first-line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.

Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, UK,

Read More